Biotech upstart goes the crowdfunding route to develop its obesity drug

Philadelphia startup Symmetry Therapeutics has an early-stage weight-loss treatment and ambitions of clinical development. Now, thanks to a crowdfunding campaign, the biotech has enough cash to move forward. As the Philadelphia Business Journal reports, Symmetry met its goal of raising just over $30,000 on Indiegogo, money that will support preclinical research on SYM401, a small-molecule therapy designed to burn fat. Story